Material Agreements

Synergy CHC Corp. entered into Purchase Agreement with Hudson Global Ventures, LLC valued at $36,000,000 (effective 2026-05-08).

“On May 8, 2026, Synergy CHC Corp. (the “Company”) entered into an equity purchase agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC (the “Investor”), pursuant to which the Company has the right, but not the obligation, to direct the Investor to purchase up to $36,000,000 of the Company’s common stock”

Emerald Holding, Inc. entered into Agreement and Plan of Merger with Emma Buyer, LLC and Emma Merger Sub, Inc. valued at $5.03 per share of Common Stock in cash (effective 2026-05-09).

“On May 9, 2026, Emerald Holding, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Emma Buyer, LLC, a Delaware limited liability company (“ Parent ”), and Emma Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“ Merger Sub ”).”

Serve Robotics Inc. /DE/ terminated Controlled Equity Offering SM Agreement with Cantor Fitzgerald & Co., Wedbush Securities Inc., Northland Securities, Inc., Ladenburg Thalmann & Co. Inc. and Seaport Global Securities LLC (collectively, the "Agents") valued at up to $150 million (effective 2026-05-07).

“On May 7, 2026, Serve Robotics Inc. (the “Company”) and each of Cantor Fitzgerald & Co., Wedbush Securities Inc., Northland Securities, Inc., Ladenburg Thalmann & Co. Inc. and Seaport Global Securities LLC (collectively, the “Agents”) agreed to terminate the Controlled Equity Offering SM Agreement, dated as of March 6, 2025 (the “Prior Sales Agreement”).”

Brand Engagement Network Inc. entered into Reseller Agreements with HighTide Energy, Inc. d/b/a Accelevate Solutions valued at 35% of gross revenue excluding hardware (effective 2026-05-07).

“On May 7, 2026, following the successful completion of due diligence, entered into two definitive Reseller Agreements (the “Commercial Agreements”) with Accelevate.”

Evolution Metals & Technologies Corp. entered into Securities Purchase Agreement with YA II PN, LTD. valued at up to $100,000,000 (effective 2026-05-07).

“On May 7, 2026, Evolution Metals & Technologies Corp. (“EMAT” or the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with YA II PN, LTD. (“Yorkville”), a fund managed by Yorkville Advisors Global, LP, pursuant to which the Company agreed to issue and sell to Yorkville convertible debentures in the aggregate principal amount of up to $100,000,000”

Unusual Machines, Inc. entered into Agreement and Plan of Merger with Upgrade Energy LLC, DroneNX LLC d/b/a Upgrade Energy, Matthew Barnard valued at $52 million (effective 2026-05-07).

“On May 7, 2026, Unusual Machines, Inc. (the “Company”), a manufacturer of NDAA-compliant drone components, entered into a $52 million agreement and plan of merger (the “Merger Agreement”), with Upgrade Energy LLC, a newly formed subsidiary of the Company (the “Surviving Company”), DroneNX LLC d/b/a Upgrade Energy (“Upgrade”), and Matthew Barnard as the Member Representative of Upgrade, pursuant to which, the Surviving Company, will acquire all of the property, rights, privileges, licenses, powers and authority of Upgrade in exchange for 1,792,012 shares of Company common stock at $13.9508 per share and $1 million cash at closing with a potential post-closing earn-out payment of up to $26 million in cash, subject to the Surviving Company achieving an annual revenue target of $10 million during a two-year calculation period following the date of the Merger Agreement (with proportional adjustment for the second year).”

Shreya Acquisition Group entered into Private Units Subscription Agreement with the Sponsor (effective 2026-05-06).

“Private Units Subscription Agreement, dated May 6, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference”

Shreya Acquisition Group entered into Letter Agreement with D. Boral Capital LLC (effective 2026-05-08).

“In connection with the Partial OA, the Company and DBC entered into a Letter Agreement, dated as of May 8, 2026 (the “Letter Agreement”) pursuant to which the parties agreed that no incremental underwriting fee would be due and no additional private placement units would be in issued in connection with the Partial OA.”

Shreya Acquisition Group entered into Underwriting Agreement with D. Boral Capital LLC, as representative of the underwriters (effective 2026-05-06).

“Underwriting Agreement, dated May 6, 2026, by and between the Company and D. Boral Capital LLC, as representative of the underwriters (“DBC”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference”

ACCENDRA HEALTH INC/VA/ entered into Commitment and Consent Letter with certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement (effective 2026-05-11).

“On May 11, 2026, Accendra Health, Inc. (the “ Company ”) entered into a Commitment and Consent Letter (the “ Commitment Letter ”) with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 (the “ 2029 Notes ”) and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding approximately all of the outstanding principal amount of the 2029 Notes and approximately 83% of the outstanding principal amount of the 2030 Notes as of May 11, 2026 and (ii) lenders under the Company’s existing Term Loan Credit Agreement (as defined below) (collectively, the “ Commitment and Consenting Parties ” and each, a “ Commitment and Consenting Party ”), (b) certain lenders under the Company’s existing Term Loan Credit Agreement consenting solely with respect to the Term B-1 Term Loan Consent (as defined below) (the “ Term B-1 Term Loan Consenting Parties ”) and (c) all lenders under the Company’s Exist”

Horizon Kinetics Holding Corp entered into Board Representative Agreement with Texas Pacific Land Corporation (effective 2026-05-05).

“On May 5, 2026, Horizon Kinetics Holding Corporation (“HKHC”) and Horizon Kinetics Asset Management LLC (together with HKHC and collectively with their respective affiliates, “Horizon”) entered into a Board Representative Agreement (the “Agreement”) with Texas Pacific Land Corporation, a Delaware corporation (“TPL”).”

Algorhythm Holdings, Inc. entered into Forbearance Agreement with SemiCab Inc. (effective 2026-05-09).

“On May 9, 2026 (the “Effective Date”), the Company and the Seller entered into a Forbearance Agreement”

QUEST DIAGNOSTICS INC entered into Indenture with The Bank of New York Mellon valued at $500,000,000 aggregate principal amount (effective 2026-05-06).

“On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”).”

CONSOLIDATED EDISON INC entered into Equity Distribution Agreement with Barclays Capital Inc., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., CIBC World Markets Corp., Jefferies LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC (as Sales Ag valued at up to an aggregate sales price of $2,000,000,000 (effective 2026-05-08).

“On May 8, 2026, Consolidated Edison, Inc. (“Con Edison” or the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Barclays Capital Inc., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., CIBC World Markets Corp., Jefferies LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC, each in its capacity as agent for the Company (each, a “Sales Agent” and collectively, the “Sales Agents”) and Barclays Bank PLC, The Bank of New York Mellon, Bank of America, N.A., Canadian Imperial Bank of Commerce, Jefferies LLC, JPMorgan Chase Bank, N.A., KeyBanc Capital Markets Inc., Mizuho Markets Americas LLC, The Bank of Nova Scotia, The Toronto-Dominion Bank and Wells Fargo Bank, National Association or their respective affiliates, each in its capacity as forward purchaser (each, a “Forward Purchaser” and collectively, the “Forward P”

LANTRONIX INC entered into Sales Agreement with Needham & Company, LLC and Canaccord Genuity LLC valued at up to $30,000,000 aggregate offering price of common stock (effective 2026-05-08).

“On May 8, 2026, Lantronix, Inc. (the "Company") entered into a Sales Agreement (the "Sales Agreement") with Needham & Company, LLC ("Needham") and Canaccord Genuity LLC ("Canaccord"), with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the "Common Stock"), having an aggregate offering price of up to $30,000,000 (the "Shares"), through either of Needham and Canaccord, each as its sales agent (together, the "Sales Agents").”

PEDEVCO CORP amended Second Amendment to Credit Agreement with Citibank, N.A., as administrative agent valued at Amended EBITDAX definition, borrowing base redetermination schedule, and reserve report delivery sch (effective 2026-05-05).

“On May 5, 2026 (the “Second Amendment Effective Date”), PEDEVCO Corp., a Texas corporation (the “Company”), entered into a Second Amendment to Credit Agreement (the “Second Amendment”) with Citibank, N.A., as administrative agent (the “Administrative Agent”), each of the guarantors party thereto, and each of the lenders party thereto.”

Cellectar Biosciences, Inc. entered into Registration Rights Agreement with certain investors (effective 2026-05-04).

“on May 4, 2026, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with certain investors”

Cellectar Biosciences, Inc. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. (effective 2026-05-04).

“on May 4, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”)”

Cellectar Biosciences, Inc. entered into Management Purchase Agreement with certain members of the executive management team of the Company (effective 2026-05-04).

“pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement””

Cellectar Biosciences, Inc. entered into Investor Purchase Agreement with certain institutional investors (effective 2026-05-04).

“On May 4, 2026, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement with certain institutional investors (the “Investor Purchaser Agreement”)”

PROSPECT CAPITAL CORP entered into Equity Distribution Agreement with A.G.P. / Alliance Global Partners valued at $400,000,000 (effective 2026-05-08).

“On May 8, 2026, Prospect Capital Corporation (the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”), dated May 8, 2026, with Prospect Capital Management L.P., Prospect Administration LLC and A.G.P. / Alliance Global Partners (together with any additional sales agents that may be added under the Equity Distribution Agreement from time to time, the “Sales Agents”).”

Live Nation Entertainment, Inc. entered into Note Purchase Agreement, Master Trust Indenture, and First Supplemental Indenture with Mount Street Mortgage Servicing Limited, HSBC Bank USA, N.A. valued at €610,000,000 fixed rate senior secured notes (effective 2026-05-08).

“On May 8, 2026, Live Nation VenueCo, LLC (“VenueCo”), a bankruptcy-remote, special purpose vehicle owned by certain bankruptcy-remote, special purpose entities (the “Participants”), which are indirect subsidiaries of Live Nation Entertainment, Inc. (the “Company”), closed its previously announced issuance of €610 million aggregate principal amount of fixed rate senior secured notes (the “Notes”).”

HNO International, Inc. entered into Securities Purchase Agreement with Monroe Street Capital Partners, LP valued at $67,500 (effective 2026-05-05).

“On May 5, 2026, HNO International, Inc. (the "Company") entered into a Securities Purchase Agreement (the "MSC Purchase Agreement") with Monroe Street Capital Partners, LP, a Delaware limited partnership (the "MSC Buyer"), pursuant to which the Company issued to the MSC Buyer a Convertible Promissory Note in the principal amount of $67,500”

TWO HARBORS INVESTMENT CORP. amended Second Amendment to the Agreement and Plan of Merger with CrossCountry Intermediate Holdco, LLC and CrossCountry Merger Corp. valued at $12.00 per share (effective 2026-05-07).

“On May 7, 2026, Two Harbors Investment Corp. (“Two Harbors”) entered into a Second Amendment to the Agreement and Plan of Merger (the “Second Amendment”), by and among Two Harbors, CrossCountry Intermediate Holdco, LLC (“CCM”) and CrossCountry Merger Corp., a wholly owned subsidiary of CCM (“Merger Sub”), to amend the terms of the previously disclosed Agreement and Plan of Merger, dated March 27, 2026 (the “Original CCM Merger Agreement”), as amended by the First Amendment to the Agreement and Plan of Merger, dated April 28, 2026 (the “First Amendment”), by and among Two Harbors, CCM and Merger Sub (the Original CCM Merger Agreement, as amended by the First Amendment and the Second Amendment, the “Amended CCM Merger Agreement”).”

Knight-Swift Transportation Holdings Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $1.5 billion aggregate principal amount (effective 2026-05-08).

“On May 8, 2026, Knight-Swift Transportation Holdings Inc. (the "Company") completed its previously announced private offering (the "Offering") of $1.5 billion aggregate principal amount of 1.00% Convertible Senior Notes due 2031 (the "Notes"), including the exercise in full of the initial purchasers' option to purchase up to an additional $200.0 million principal amount of the Notes.”

Contango Silver & Gold Inc. terminated Lease Agreement with Alaska Hardrock Inc. (effective 2026-05-04).

“the 2% NSR Royalty contained in the Lease Agreement was effectively terminated”

Contango Silver & Gold Inc. entered into Purchase Agreement with Alaska Hardrock Inc. valued at $16,074,000 (effective 2026-05-04).

“On May 4, 2026, Contango Lucky Shot Alaska, LLC (“LSA”), a wholly-owned subsidiary of Contango Silver & Gold Inc. (“Contango” or the “Company”), entered into a purchase and sale agreement (the “Purchase Agreement”) and executed a promissory note (the “Promissory Note”) with Alaska Hardrock Inc. (“AHI”) to acquire 100% ownership of the Company’s Lucky Shot project”

Citius Pharmaceuticals, Inc. amended Third Amendment to Promissory Note with Citius Oncology, Inc. (effective 2026-05-04).

“the Company and Citius Oncology entered into a Third Amendment to Promissory Note (the “Third Amendment”), which amends the promissory note, dated August 16, 2024, as previously amended on September 10, 2025 and December 10, 2025, issued by the Citius Oncology to the Company in the original principal amount of $3,800,111 (the “Promissory Note”)”

Chiron Real Estate Inc. entered into Investor Rights Agreement with Purchasers (including Maewyn XRN LP and others) (effective 2026-05-06).

“In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.”

Chiron Real Estate Inc. entered into Investment Agreement with Maewyn XRN LP and other purchasers valued at up to $100.0 million (effective 2026-05-06).

“On May 6, 2026, Chiron Real Estate Inc. (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Maewyn XRN LP (the “Maewyn Purchaser”) and each other purchaser that may become a party to this Investment Agreement from time to time (collectively, the “Purchasers”). Pursuant to the Investment Agreement, the Company agreed to issue and sell to the Purchasers a total of 1,000,000 shares of a new series of 6.00% Series C Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), at a purchase price of $100.00 per share, for aggregate gross proceeds of up to $100.0 million (the “Commitment Amount”) (the “Private Placement”).”

National Healthcare Properties, Inc. entered into PSA with an affiliated third party valued at approximately $528 million (effective 2026-05-04).

“On May 4, 2026, National Healthcare Properties, Inc. (the “Company”) and certain of its subsidiaries entered into a definitive purchase and sale agreement (the “PSA”) with an affiliated third party to sell a portfolio of 86 outpatient medical facilities for approximately $528 million”

Via Renewables, Inc. amended amended and restated subordinated promissory note (Note No. 9) with Retailco, LLC valued at up to $25.0 million.

“In connection with entering into the Credit Agreement, the Company entered into an amended and restated subordinated promissory note (Note No. 9) (the “Subordinated Debt Facility”) with Spark HoldCo and Retailco, LLC (“Retailco”).”

Via Renewables, Inc. entered into Credit Agreement with Bank OZK valued at up to $300.0 million (effective 2026-05-06).

“On May 6, 2026, Via Renewables, Inc., a Delaware corporation (the “Company”), and Spark Holdco, LLC (“Spark Holdco”, and together with certain subsidiaries of the Company and Spark Holdco, the “Co-Borrowers”) entered into a Credit Agreement (the “Credit Agreement”), with Bank OZK, as administrative agent (the “Agent”), swing bank, swap bank, issuing bank, joint-lead arranger, sole bookrunner and syndication agent.”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreement with Streeterville (effective 2026-05-05).

“On May 5, 2026, the Company entered into an Exchange Agreement (the “Note Exchange”) with Streeterville.”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreements with Streeterville (effective 2026-04-30).

“On April 30, 2026, the Company entered into three Exchange Agreements (the “Exchanges”) with Streeterville.”

Industrial Logistics Properties Trust terminated a credit facility with Citi Real Estate Funding Inc., UBS AG New York Branch, Bank of America, N.A., Bank of Montreal and Morgan Stanley Bank, N.A. valued at $1.4 billion (effective 2026-05-08).

“and then terminated the agreement governing the floating rate mortgage loan in accordance with its terms and without penalty.”

Industrial Logistics Properties Trust entered into a credit facility with Wells Fargo Bank, National Association, Citi Real Estate Funding Inc., Morgan Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch valued at $1.62 billion (effective 2026-05-08).

“On May 8, 2026, certain subsidiaries of our consolidated joint venture, Mountain Industrial REIT LLC, or Mountain JV, entered into a mortgage loan agreement with Wells Fargo Bank, National Association, Citi Real Estate Funding Inc., Morgan Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively, the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured by 90 of its properties, or the Loan.”

AVAI BIO, INC. terminated Joint Venture and License Agreement with Ainnova Tech Inc. valued at No termination penalties or further financial obligations will be incurred by either party. (effective 2026-05-07).

“On May 7, 2026, Avai Bio, Inc., formerly known as Avant Technologies Inc. (the “Company” or “AVAI”), and Ainnova Tech Inc. (“Ainnova” or “AINN”) entered into a Mutual Termination Agreement (the “Termination Agreement”) to terminate, by mutual consent, the Joint Venture and License Agreement dated November 8, 2024 (effective as of November 11, 2024) (the “License Agreement”).”

BridgeBio Pharma, Inc. terminated Equity Distribution Agreement, dated May 4, 2023 with Goldman Sachs & Co. LLC and Leerink Partners LLC (formerly known as SVB Securities LLC) (effective 2026-05-07).

“On May 7, 2026, in connection with entering into the Agreement, the Company agreed with Goldman Sachs and Leerink Partners (formerly known as SVB Securities LLC), to terminate that certain Equity Distribution Agreement, dated May 4, 2023, by and among the Company, Goldman Sachs and Leerink Partners, effective as of May 7, 2026.”

BridgeBio Pharma, Inc. entered into Equity Distribution Agreement with Goldman Sachs & Co. LLC and Leerink Partners LLC valued at $500,000,000 (effective 2026-05-07).

“On May 7, 2026, the Company entered into an Equity Distribution Agreement (the “Agreement”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) and Leerink Partners LLC (“Leerink Partners”, and together with Goldman Sachs, the “Sales Agents”) with respect to an “at-the-market” offering program under which the Company may issue and sell, from time to time at its sole discretion and pursuant to a prospectus supplement, shares of its common stock, par value $0.001 per share (“Common Stock”), having an aggregate offering price of up to $500,000,000 (the “Placement Shares”), through the Sales Agents.”

Stardust Power Inc. entered into At Market Issuance Sales Agreement with B. Riley Securities, Inc. valued at $5,000,000 (effective 2026-05-08).

“On May 8, 2026, Stardust Power Inc. (the “Company”) entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”). Pursuant to the terms of the Sales Agreement, the Company may sell from time to time through the Agent, shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $5,000,000 (the “Shares”).”

Sono Group N.V. entered into Share Purchase and Transfer Agreement with Vorratsla-160 M UG, Vorratsla-161 M UG, and Sono Motors GmbH valued at €1.00 in the aggregate (effective 2026-05-04).

“On May 4, 2026 (the “Signing Date”), the Company entered into a Share Purchase and Transfer Agreement (the “SPA”) with (i) Vorratsla-160 M UG (haftungsbeschränkt), a German limited liability company whose sole shareholder is Denis Azhar, and (ii) Vorratsla-161 M UG (haftungsbeschränkt), a German limited liability company whose sole shareholder is Jan Schiermeister (together, the “Purchasers”), and Sono Motors GmbH, a German limited liability company (“Sono Motors”).”

European Wax Center, Inc. terminated Series 2022-1 Supplement and Base Indenture (April 6, 2022) with Citibank, N.A. valued at $388.1 million prepayment including $385,000,000 principal plus $3.1 million accrued interest (effective 2026-05-08).

“Concurrently with the closing of the Mergers, the Master Issuer prepaid in full all outstanding Series 2022-1 5.50% Fixed Rate Senior Secured Notes, Class A-2 issued pursuant to that certain Series 2022-1 Supplement, dated as of April 6, 2022, as amended, supplemented, amended and restated or otherwise modified from time to time, by and between the Master Issuer and Citibank, N.A., as trustee, and that certain Base Indenture, dated as of April 6, 2022, as amended, supplemented, amended and restated or otherwise modified from time to time, by and between the Master Issuer and Citibank, N.A., as trustee and securities intermediary, and all pledge, security, management and other agreements and documents related thereto.”

European Wax Center, Inc. entered into Amended and Restated Base Indenture and Series 2026-1 Supplement with Citibank, N.A. valued at $460,000,000 aggregate principal amount of Series 2026-1 6.40% Fixed Rate Senior Secured Notes, Clas (effective 2026-05-08).

“As previously disclosed, European Wax Center, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger, dated as of February 9, 2026 (the “ Merger Agreement ”), by and among Glow Midco, LLC, a Delaware limited liability company (“ Parent ”), Glow Merger Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub Inc. ”), Glow Merger Sub 2, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent (“ Merger Sub LLC ,” and together with Merger Sub Inc., the “ Merger Subs ”) and EWC Ventures, LLC, a Delaware limited liability company (“ Opco ”), pursuant to which (i) Merger Sub Inc. merged with and into the Company (the “ Corporate Merger ”), with the Company surviving the Corporate Merger as the surviving corporation (the “ Surviving Corporation ”) and a wholly owned subsidiary of Parent and (ii) Merger Sub LLC merged with and into Opco, with Opco surviving as the surviving limited liability company”

Galaxy Digital Inc. entered into Open Market Sale Agreement with Jefferies LLC, BNY Mellon Capital Markets, LLC and UBS Securities LLC valued at $500,000,000 (effective 2026-05-08).

“On May 8, 2026, Galaxy Digital Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC, BNY Mellon Capital Markets, LLC and UBS Securities LLC (each, an “Agent” and together, the “Agents”), pursuant to which the Company may sell, from time to time, at its option, shares of the Company’s Class A common stock, $0.001 par value per share (the “Common Shares”), through the Agents, as sales agents (the “ATM Offering”).”

Quantum Cyber N.V. amended Amendment No. 1 to Equity Distribution Agreement with Maxim Group LLC valued at aggregate offering amount increased from up to $10,000,000 to up to $100,000,000 (effective 2026-05-04).

“On May 4, 2026, Quantum Cyber N.V. (the “Company”) entered into that certain Amendment No. 1 to Equity Distribution Agreement (“Amendment No. 1”) with Maxim Group LLC (the “Sales Agent”), which amends that certain Equity Distribution Agreement, dated as of October 3, 2025, between the Company and Sales Agent (the “Original Agreement” and, together with Amendment No. 1, the “Sales Agreement”).”

Brag House Holdings, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2026-05-04).

“In connection with the Offering, on May 4, 2026, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers.”

Brag House Holdings, Inc. entered into Purchase Agreement with certain institutional investors valued at $2,500,000 (effective 2026-05-04).

“On May 4, 2026, Brag House Holdings, Inc., a Delaware corporation (the “Company”), entered into a Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (each, a “Purchaser” and collectively, the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers, and the Purchasers agreed to purchase from the Company, Senior Secured Convertible Notes, each dated May 4, 2026 (collectively, the “Notes”), in an aggregate original principal amount of $2,500,000 (the “Offering”).”

PGIM Private Credit Fund entered into Credit Facility with Deutsche Bank AG, New York Branch, as facility agent, and State Street Bank and Trust Company, as collateral agent and collateral custodian, the Fund, as equityholder and servicer, the SPV, as borrower, and the lenders from time to time party thereto valued at $100 million (effective 2026-05-05).

“On May 5, 2026 (the "Closing Date"), PGIM Private Credit Fund ABL LLC (the "SPV"), a wholly owned subsidiary of PGIM Private Credit Fund (the "Fund"), entered into a loan financing and servicing agreement (the "Credit Facility") with Deutsche Bank AG, New York Branch, as facility agent, and State Street Bank and Trust Company, as collateral agent and collateral custodian, the Fund, as equityholder and servicer, the SPV, as borrower, and the lenders from time to time party thereto”

New Horizon Aircraft Ltd. entered into Purchase Agreements with certain institutional investors valued at aggregate gross proceeds ... of approximately $19.9 million (effective 2026-05-06).

“On May 6, 2026, New Horizon Aircraft Ltd. (the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”) an aggregate of 9,254,889 our Class A ordinary shares, without par value (the “Shares", and each Class A ordinary share with no par value in the authorized share structure of the Company, a “Common Share”). The offering price per Share is $2.15, for aggregate gross proceeds to the Company from the Offering of approximately $19.9 million”